Publication:
Re: Levy-Clarke et al.: expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders (Ophthalmology 2014;121:785-96)

Simple item page
dc.contributor.coauthorTuğal-Tutkun, İlknur
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorÖnal, Sumru
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T22:49:12Z
dc.date.issued2014
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue10
dc.description.openaccessNO
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume121
dc.identifier.doi10.1016/j.ophtha.2014.05.033
dc.identifier.eissn1549-4713
dc.identifier.issn0161-6420
dc.identifier.quartileQ1
dc.identifier.scopus2-s2.0-84908139012
dc.identifier.urihttps://doi.org/10.1016/j.ophtha.2014.05.033
dc.identifier.urihttps://hdl.handle.net/20.500.14288/6462
dc.identifier.wos342697300007
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofOphthalmology
dc.subjectOphthalmology
dc.titleRe: Levy-Clarke et al.: expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders (Ophthalmology 2014;121:785-96)
dc.typeLetter
dspace.entity.typePublication
local.contributor.kuauthorÖnal, Sumru
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files

Collections

Publications without Fulltext